Branded generics drugs
are similar to the innovator products but are marketed and sold under different brand names. The color, size and shape of the brands of the same medicine may vary depending on the manufacturing company. Branded generics cover a broad range of treatments including antibiotics, antifungal medications and diabetic therapies among many others. Global market for branded generics is witnessing a significant growth in near future as numerous pharmaceutical products are going to be of patent in the coming years. Branded generics find the new ways to formulate drugs that have lost patent protection. Branded generics in emerging markets offer big pharmaceutical plays a viable growth. It assures consumers that the medicines are proven to be safe and effective. Generic drugs are less expensive and time consuming for their development. Branded generic drugs are used to treat hypertension, diabetes, back pain, arthritis, and thyroid disfunctioniong and others.
This report segments the
branded generics market
by type, by application and by distribution. Branded generics are of two major types; value added branded generics and trade named branded generics. By application, the market is classified into cardiovascular drugs, anti-cancer drugs, CNS drugs, and anti-infective drugs. By distribution, the market for branded generics includes retail pharmacies, hospital pharmacies and clinics.
The overall branded generics market is also studied for different region and their major countries. North America is the largest market due to its increasing demand for cost effective medicines followed by Europe, APAC and RoW. Branded generics market is poised to reach $XXm at a CAGR of XX% in the forecast period.